NCT05943678View on ClinicalTrials.gov

Novel Metabolic Muscular Biomarkers in Pompe Disease - a Non-invasive Magnetic Resonance Exploratory Pilot Study.

Active, not recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

August 15, 2023

Primary Completion Date

August 15, 2028

Study Completion Date

October 15, 2028

Conditions
Pompe DiseaseMcArdle Disease
Interventions
DEVICE

Siemens Magnetom 7T Plus

Magnetic Resonance Spectroscopy

Trial Locations (1)

1090

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT05943678 - Novel Metabolic Muscular Biomarkers in Pompe Disease - a Non-invasive Magnetic Resonance Exploratory Pilot Study. | Biotech Hunter | Biotech Hunter